Express News | Algernon Pharmaceuticals Inc: Announces Non-Brokered Private Placement for Gross Proceeds of $250,000 at Issue Price of $0.12 per Unit

ReutersJul 11 16:15 ET

Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services

Stockhouse May 21 07:00 ET

Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke...

Stockhouse Apr 24 07:47 ET

Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research's Pitch,...

Stockhouse Apr 11 07:00 ET

Algernon Pharmaceuticals to Move Forward With Psychedelic Drug DMT Stroke Research Program as Its...

Stockhouse Apr 1 07:00 ET

Algernon Pharmaceuticals Says Acquisition of Ifenprodil Program Completed by US Company

MT NewswiresMar 27 13:02 ET